GeneralConnection.com
➔
Dictionary
Dictionary Search
Go Find!
xenon
Synonyms
Noun
1. Xe
2. atomic number 54, chemical element, element, noble gas, inert gas, argonon
Usage
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing - The Motley Fool
Xenon Pharmaceuticals (NASDAQ: XENE) shows 5.78M-share holding, 6.26% - Stock Titan
Xenon gas does not help elite climbers - UW Homepage
Forty years and multi-tonne xenon detectors have brought dark-matter searches to the 'neutrino fog' without a signal, while a tentative hint surfaces in LIGO data built to listen for colliding black holes — and the pattern of paradigms exhausting themselves into a - Space Daily
Analysts tout market potential of Xenon’s epilepsy drug on Phase III win - Clinical Trials Arena
Xenon’s seizure drug study reads out soon. Here’s what to expect - statnews.com
Xenon to Report Q1 2026 Financial Results on May 7, 2026 - Yahoo Finance
Xenon Pharmaceuticals: Q1 Earnings Snapshot - kare11.com
Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations - BioSpace
Xenon phase 3 epilepsy readout 'blows away' expectations, stock soars - Fierce Biotech
Krypton/Xenon separation at room temperature in a flexible coordinative framework sorbent - Nature
The First Xenon-Powered Everest Climb Is Coming This Spring - Climbing Magazine
Xenon Pharmaceuticals stock (CA98420N1050): epilepsy data and capital raise put biotech in focus - AD HOC NEWS
Janus Henderson reports 4.5% stake in Xenon Pharmaceuticals (XENE) filing - Stock Titan
Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus - Yahoo Finance
Driehaus files Schedule 13G/A disclosing 4.87% in Xenon (XENE) - Stock Titan
Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here - Yahoo Finance
Xenon Pharmaceuticals (XENE) director exercises options, now holds 10,641 shares - Stock Titan
Xenon Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase 3 X TOLE2 Success And Extended Cash Runway - Yahoo Finance
Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial - statnews.com
Xenon Reports Q1 2026 Financial Results and Provides Business Update - Yahoo Finance
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 - BioSpace
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward - Yahoo Finance
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development - dicardiology.com
EyeCare4Kids Partners With Xenon Ophthalmics to Expand Access to Comprehensive Vision Exams - VisionMonday.com
Big cash raise and strong Phase 3 results headline Xenon (XENE) Q1 2026 - Stock Titan
Size-inverse molecular sieving xenon/krypton separation through cation-tuned gating effect within Linde Type A zeolites - Nature
Seven new Xenon hires get stock awards priced at $56.04 - Stock Titan
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering - GlobeNewswire
A seizure drug filing is next, but Xenon has 5 more Phase 3 studies running - Stock Titan
Xenon Pharmaceuticals to Announce Topline Data from Phase 3 X-TOLE2 Study of Azetukalner for Focal Onset Seizures - Quiver Quantitative
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why - Yahoo Finance
Is Xenon Pharmaceuticals (XENE) Quietly Reframing Its Epilepsy Bet Through Equity Awards and New Data? - Yahoo Finance
Xenon tees up FDA filing after seizure med delivers 'home run' in Phase III - FirstWord Pharma
Assessing Xenon Pharmaceuticals (XENE) Valuation After New Phase 3 Azetukalner Epilepsy Data - simplywall.st
Can Xenon Gas Really Replace Traditional Acclimatization on Mount Everest? - Global Rescue
Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE) - Seeking Alpha
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update - Yahoo Finance
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting - Yahoo Finance
Xenon Pharmaceuticals (XENE) Is Down 6.7% After $650 Million Follow-On Offering And Phase 3 Epilepsy Win - Yahoo Finance
Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout (NASDAQ:XENE) - Seeking Alpha
A Look At Xenon Pharmaceuticals (XENE) Valuation After Wolfe Research’s New Favorable Coverage - Yahoo Finance
Xenon to Present at Upcoming Investor Conferences - Yahoo Finance
Xenon to Announce Topline Results from Phase 3 X-TOLE2 - GlobeNewswire
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results - GlobeNewswire
Rab Xenon Synthetic Jacket Review - Switchback Travel
Xenon Pharmaceuticals Announces Closing of $747.5 Million - GlobeNewswire
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ... - Yahoo Finance
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know - The Motley Fool
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data - The Motley Fool
Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference - Yahoo Finance
The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE) - FinancialContent
Can Xenon Help You Climb Everest Faster? These Scientists Aren't Buying the Hype. - Outside Magazine
Xenon Pharmaceuticals (XENE) 2026 proxy details board elections and new equity plan - Stock Titan
Xenon to Present at Upcoming Investor Conferences - GlobeNewswire
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - GlobeNewswire
$500M stock sale: neuroscience drug maker Xenon tests market appetite - Stock Titan
Xenon's Phase 3 Supports A 'Buy' Despite Its Premium (NASDAQ:XENE) - Seeking Alpha
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Cantor Fitzgerald raises Xenon Pharmaceuticals stock price target to $55 - Investing.com
XENON Launches CIXL Pulsed Light System for Food Safety, Pathogen Control - Food Safety Magazine
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Xenon Pharmaceuticals (XENE) boosts 2025 inducement equity plan share reserve - Stock Titan
Xenon Pharmaceuticals (XENE): Losses Widen 37% Annually, Challenging Bullish Revenue Growth Expectations - Yahoo Finance
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE) - FinancialContent
Stocks With Rising Relative Strength: Xenon Pharmaceuticals - Investor's Business Daily
Xenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy - Yahoo Finance
Feature Satellite propulsion lifts krypton and xenon demand - gasworld
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 - Yahoo Finance
Jefferies raises Xenon Pharmaceuticals stock price target on epilepsy drug potential - Investing.com
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Contamination on Extreme Ultraviolet Optics Induced by Xenon-Based Electrodeless Z-Pinch Plasma - Wiley
Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations - BioSpace
Xenon lines up four investor conference presentations in Q2 2026 - Stock Titan
Xenon Pharmaceuticals Nets $707.7 Million in $57 Share Offering With Pre-Funded Warrants - TradingView
Xenon Pharmaceuticals Announces Proposed Public Offering - Scott Coop
BofA raises Xenon Pharmaceuticals price target on trial success - Investing.com
When climbing Mount Everest, is it cheating to use xenon gas? - National Geographic
Ian Mortimer, Xenon Pharma CEO, sells $1.14m in shares - Investing.com
Biotech Xenon raises $650M in stock sale at $57 a share - Stock Titan
Xenon Pharmaceuticals to report epilepsy drug trial results Monday - Investing.com
HydroX, a light dark matter search with hydrogen-doped liquid xenon time projection chambers - Nature
FDA rejection is a reality check on agency rhetoric - statnews.com
Xenon brings 48-month epilepsy drug data and Phase 3 results to AAN - Stock Titan
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for - GlobeNewswire
Commodore Announces Xenon 3: Hyperblast For Steam, Switch And PlayStation - Time Extension
JPMorgan reiterates Overweight rating on Xenon Pharmaceuticals stock - Investing.com
Xenon Pharmaceuticals Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Operation of a dual-phase xenon detector with wavelength sensitivity from ultraviolet to infrared - Frontiers
Xenon price today, XNN to USD live price, marketcap and chart - CoinDesk
Xenon Gas Shows Promise in Treating Alzheimer’s Disease; Human Trials to Follow - Anesthesiology News
Why Xenon’s Stock Is Sliding Despite Drug Progress - TipRanks
Xenon (1984) - IMDb
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
Ten new Xenon hires receive 42,300 stock options vesting over 4 years - Stock Titan
Xenon Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Evaluating the Resistance of Bifacial Perovskite Photodetectors to Xenon Ion Irradiation - Wiley
UCB says Bimzelx tops Skyrizi in trial; Xenon, Dianthus set share sales - Endpoints News
Foreign Language Equivalents
Foreign Language Equivalents of 'xenon'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
xenom, xenoon, xnon, xenob, xrnon, enon, zenon, xeenon, xeon, xebon, exnon, xennon, xneon, xemon, xenin, xenpn, cenon, xeno, xenonn, xeonn, xwnon, xxenon, xenn, xenno
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z